Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

390

HTML

2992

Figures (1-2)

209

Tables (1-3)

181

Sum=3772

Jun 1, 2004 (publication date) through Nov 30, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jun 1, 2004; 10(11): 1643-1646
Published online Jun 1, 2004. doi: 10.3748/wjg.v10.i11.1643

Figure 1 Concentrations of tumor M₂-PK in patients with gastrointestinal tumors and controls.

Figure 2 Comparison of sensitivities of tumor M₂-PK, CEA, CA72-4 in different gastrointestinal tumors.

Citation: Zhang B, Chen JY, Chen DD, Wang GB, Shen P. Tumor type M₂ pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol 2004; 10(11): 1643-1646
URL: https://www.wjgnet.com/1007-9327/full/v10/i11/1643.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i11.1643